Ambulant Laparoscopic Nephrectomy; Are There Limiting Factors

January 22, 2018 updated by: Nessn Azawi, Zealand University Hospital

Ambulant Laparoscopic Nephrectomy

Background Fast-track concepts reduced hospital stay from 15-20 days to three days for patients who underwent a colon resection [1-5]. A well-designed pilot study determined the efficacy of a fast-track program for a laparoscopic radical nephrectomy, and the fast-track group was discharged earlier from the recovery room median (74+/-23 v 103+/-47 minutes) as well as from the hospital median (41+/-11 v 59+/-11 hours) [6]. Implementation of the principles of the fast-track program shortened the postoperative hospital stay from eight to four days for patients who underwent an open radical nephrectomy [7]. Taek-Gu Lee et al. documented how early mobilization after colon surgery resulted in reduced recovery times without increased complications [8]. Laparoscopic surgery is minimal invasive with less surgical stress, morbidity and mortality [9]. The use of laparoscopic nephrectomy in Denmark reduces the hospital stay to 5.2 days which did not meet the foreign countries outcome [06].

Therefore a combination of the advantages of laparoscopic surgery and the fast-track concepts could be used by nephrectomies. However, no prospective studies describing the course after nephrectomies, where these advantages are exploited and it is important to make a basic study to describe and understand the factors of surgical outcome.

Aim of study To describe the postoperative period after laparoscopic trans-peritoneal nephrectomy that performed as an ambulatory procedure.

Method A prospective study will involve 62 patients who have been diagnosed with Cancer Renis DC649.

All patients will receive the results of CT-scanning at outpatient and of them who meet the inclusion criteria for the study will be informed about the study and will receive a written information according to appendix 1., and a new time with (NA) to get the results for kidney function and oral information about the study as well as their acceptation to be connected to the study, those patients will receive a standard recommendation to be discharged from hospital on the day of their operation and they will restart their normal activities the day after the operation unless there are preventing factors. All patients will be thoroughly informed by the examiner how to complete the questionnaire and will come through different tests according to appendix 2., a blood test will be taken according to appendix 12.

All patients should have a CT-scanning of abdomen, chest X-ray and kidney function test before the operations.

Statistic The number of patients, have been decided to be included to each study, is based on the realized number of nephrectomy operations that can be done during the specified period within each department and not on the statistic power of study.

The Scheffé's test will be used for multiple comparisons. The correlation between variables will be evaluated by using the Spearman's rank correlation coefficient. P values less than 0.05 is considered significant. Statistical analyses will be performed by SPSS statistic program software.

Publications The results of each study, irrespective of whether these are positive or negative, will be published in international scientific journals and will be distributed at relative conferences. The published articles will have Azawi NH as first author, Christensen T as last author and co-authors according to Vancouver rules.

Ethics The study will be reported to the Danish National Committee on Biomedical Research Ethics and regionsjaelland paraplygodtkendelsen data control, Ph.D. student (NA) will apply for enrollment to the PhD programme at the University of Copenhagen. Consent forms will be received from all patients and they will receive written information about project. The project will protect all of the data gathered.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Roskilde, Denmark, 4000
        • Roskilde Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

28 years to 68 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patient between 30-70 years old.
  2. Diagnosed as Cancer Renis
  3. Can read and understand Danish
  4. No cardiac disease
  5. No metastatic disease

Exclusion Criteria:

  1. Mentally sick patient
  2. Dement
  3. Living alone
  4. Cardiac problem
  5. Multiple surgery previously
  6. Per operative bleeding with the need to blood transfusion
  7. Operation time at afternoon

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Laparoscopic Nephrectomy
The patients with a renal cancer diagnosis with be schedule to enter the project if they meet the inclusion criteria of the project and the postoperative period will be recorded to identified the limiting factors for ambulant laparoscopic nephrectomy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identification of the limiting factors for ambulant laparoscopic nephrectomy
Time Frame: 8 hours
The patient will asked a direct question after the operation if they can not be discharged at the operation day. what is the main reason not to be discharged at this time?
8 hours
Identification of the limiting factors for ambulant laparoscopic nephrectomy
Time Frame: 1 day
The patient will asked a direct question after the operation if they can not be discharged at the operation day. what is the main reason not to be discharged at this time?
1 day
Identification of the limiting factors for ambulant laparoscopic nephrectomy
Time Frame: 2 day
The patient will asked a direct question after the operation if they can not be discharged at the operation day. what is the main reason not to be discharged at this time?
2 day
Identification of the limiting factors for ambulant laparoscopic nephrectomy
Time Frame: 3 day
The patient will asked a direct question after the operation if they can not be discharged at the operation day. what is the main reason not to be discharged at this time?
3 day
Identification of the limiting factors for ambulant laparoscopic nephrectomy
Time Frame: 4 day
The patient will asked a direct question after the operation if they can not be discharged at the operation day. what is the main reason not to be discharged at this time?
4 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain,Nausea,Vomiting,Fatigue,Dizziness
Time Frame: 3 hours
The postoperative period of 30 days will be observed by using visual analog skala (VAS)for Pain,Nausea,Vomiting,Fatigue,Dizziness.
3 hours
Pain,Nausea,Vomiting,Fatigue,Dizziness
Time Frame: 8 hours
The postoperative period of 30 days will be observed by using visual analog skala (VAS)for Pain,Nausea,Vomiting,Fatigue,Dizziness.
8 hours
Pain,Nausea,Vomiting,Fatigue,Dizziness
Time Frame: 1 day
The postoperative period of 30 days will be observed by using visual analog skala (VAS)for Pain,Nausea,Vomiting,Fatigue,Dizziness.
1 day
Pain,Nausea,Vomiting,Fatigue,Dizziness
Time Frame: 2 day
The postoperative period of 30 days will be observed by using visual analog skala (VAS)for Pain,Nausea,Vomiting,Fatigue,Dizziness.
2 day
Pain,Nausea,Vomiting,Fatigue,Dizziness
Time Frame: 3 day
The postoperative period of 30 days will be observed by using visual analog skala (VAS)for Pain,Nausea,Vomiting,Fatigue,Dizziness.
3 day
Pain,Nausea,Vomiting,Fatigue,Dizziness
Time Frame: 4 day
The postoperative period of 30 days will be observed by using visual analog skala (VAS)for Pain,Nausea,Vomiting,Fatigue,Dizziness.
4 day
Pain,Nausea,Vomiting,Fatigue,Dizziness
Time Frame: 5 day
The postoperative period of 30 days will be observed by using visual analog skala (VAS)for Pain,Nausea,Vomiting,Fatigue,Dizziness.
5 day
Pain,Nausea,Vomiting,Fatigue,Dizziness
Time Frame: 10 day
The postoperative period of 30 days will be observed by using visual analog skala (VAS)for Pain,Nausea,Vomiting,Fatigue,Dizziness.
10 day
Pain,Nausea,Vomiting,Fatigue,Dizziness
Time Frame: 30 day
The postoperative period of 30 days will be observed by using visual analog skala (VAS)for Pain,Nausea,Vomiting,Fatigue,Dizziness.
30 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nessn Htum Azawi, M.D., Zealand University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

February 1, 2015

Study Completion (Actual)

February 1, 2015

Study Registration Dates

First Submitted

May 12, 2012

First Submitted That Met QC Criteria

May 15, 2012

First Posted (Estimate)

May 16, 2012

Study Record Updates

Last Update Posted (Actual)

January 24, 2018

Last Update Submitted That Met QC Criteria

January 22, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • SJ-267

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nephrectomy

Clinical Trials on Ambulant laparoscopic nephrectomy

3
Subscribe